Sponsored
Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say
Posted
India’s pharma sector has downplayed the impact of US President Trump’s 25% tariff, warning instead of severe consequences for American healthcare. Industry leaders stressed India’s key role in supplying affordable medicines to the US and predicted shortages, higher costs, and a 3–5 year struggle for the US to find alternatives.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
'You have been gravely misled by Asim Munir': Baloch leader's open letter to Trump; oil reserves not in Pakistan
Baloch leader Mir Yar Baloch cautioned Donald Trump in an open letter, asserting that General...
Kab Banoge Crorepati? In how many years can you get Rs 1 crore with Rs 25,000 monthly investment - explained
Achieving a ₹1 crore corpus requires disciplined investing, with the timeline varying based on...
Ex-president should not be allowed to join active politics, says Pariyar
BHAKTAPUR: Nepali Congress Deputy-General Secretary Jeevan Pariyar has argued that constitutional...